Clinical trials with taxpayer money were conducted at major universities to study the long-term effects of meditation and psychedelics, such as psilocybin and MDMA, on mental health. These studies showed positive results, including 66% long-term depression relief with two appropriately spaced MDMA sessions and a clinician present.